
Mshubet Tablet 10 mg (Empagliflozin 2L-Proline)
15.107mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Empagliflozin 2L-Proline is a blood glucose-lowering agent used for the treatment of type 2 diabetes.
MFDS ingredient code M285825
Empagliflozin 2L-Proline is a diabetes treatment ingredient belonging to the SGLT2 inhibitor class. This ingredient is used to block the reabsorption of glucose in the kidneys to help control blood glucose levels.
This ingredient inhibits the sodium-glucose cotransporter 2 (SGLT2) in the kidneys, increasing the excretion of glucose in urine. As a result, it lowers the concentration of glucose in the blood and helps with blood sugar control.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other SGLT2 inhibitors, Empagliflozin 2L-Proline is a formulation that enhances stability in the 2L-Proline form. Additionally, cardiovascular protective effects have been reported, which is advantageous for the management of diabetic patients.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.